Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2) - Concepedia

Concepedia

Publication | Open Access

Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)

DOI Full Paper Access

226

Citations

6

References

2016

Year

Arthur Kavanaugh, Joel M. Kremer, L Ponce, Regina Cseuz, O. V. Reshetko, Mykola Stanislavchuk, Maria Greenwald, Annegret Van der Aa, Frédéric Vanhoutte, Chantal Tasset,

Annals of the Rheumatic Diseases

Abstract

NCT01894516.

References

	Year	Citations

Page 1